New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Eli Lilly and Company

LLY

Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.

Revenue
+38.6%
EPS
+16.3%
Free cash flow
+21.8%
Total debt
+15.0%

Quarter to September 2026, against a year earlier

1,354.78 3.13 +0.23%
Market cap
$1.27T
P/E
43.9×
Fwd P/E FY26e
42.2×
Dividend yield
0.51%
F-score
7/9
ROIC
26.4%
Net debt / EBITDA
1.2×
Payout ratio
0.2×

Ratios over time Q4 FY25 to Q3 FY26

Returns on capital

ROIC was 26.4% in Q3 FY26, against a low of 26.3% in Q2 FY26. ROE, at 86.0%, is far above it because equity is small against the capital the business uses.

ROEROIC
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
ROE101.2%107.5%102.3%86.0%
ROIC26.6%30.2%26.3%26.4%

Debt

Net debt is 4.45× a year’s EBITDA. Debt is 1.17× equity, against 1.62× in Q2 FY26.

Debt / equityNet debt / EBITDA
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Debt / equity1.6×1.3×1.6×1.2×
Net debt / EBITDA4.1×3.6×4.8×4.5×

Cash cycle, in days

Customers pay in 107 days, inventory is held 469 days and suppliers are paid in 149. Cash is tied up for 426 days between paying for goods and being paid.

Cash cycleDays to pay suppliersDays to be paid
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Cash cycle389387402426
Days to pay suppliers178148169149
Days to be paid113107108107

Per share, from Q4 FY25

Since Q4 FY25, per share: free cash flow has grown 120.5%; revenue has grown 33.5%; book value has grown 52.7%.

Free cash flowRevenueBook value
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Free cash flow1.0×1.3×2.0×2.2×
Revenue1.0×1.1×1.2×1.3×
Book value1.0×1.2×1.3×1.5×
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
37.56 40.25 32.67 46.83

+8 more quarters

P/S ratio
11.94 13.44 11.39 14.79
P/FCF ratio
47.21 52.49 58.67 86.31
P/Operating CF
90.55 100.13 154.27 299.01
P/B ratio
25.63 31.59 26.37 36.34
EV/Sales
12.50 14.01 11.88 15.34
EV/EBITDA
29.23 31.24 25.58 35.32
EV/FCF
49.45 54.75 61.21 89.46
Current Ratio
1.39 1.35 1.50 1.58
Net Debt/EBITDA
4.45 4.83 3.62 4.10
Debt/Equity
1.17 1.62 1.26 1.60
Earnings Yield
2.66% 2.48% 3.06% 2.14%
Free Cash Flow Yield
2.12% 1.91% 1.70% 1.16%
Free Cash Flow per Share
9.22 8.69 3.36 0.76
Book value per Share
45.15 37.96 34.88 29.57
Free Cash Flow
8,219.00 7,757.00 3,007.00 678.00
EV/EBIT
31.06 33.19 27.23 38.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated Nov 18, 2026